🔎 Trials Near Me

Home › Diffuse Scleroderma › Illinois › Chicago

Pag-aaral pangklinika para sa Diffuse Scleroderma sa Chicago, IL

Isang pag-aaral para sa Diffuse Scleroderma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Chicago. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis

Nagre-recruitPhase 2
  • University of Chicago Hospitals, Chicago
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT06470048

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

Nagre-recruitPhase 1
  • The University of Chicago Medical Center, Chicago
Edad 18 hanggang 74 · Lahat ng kasarian · Na-update Set 10, 2026 · NCT07085104

A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

Nagre-recruitPhase 2/3
  • GSK Investigational Site, Chicago
Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT05878717

A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

Nagre-recruitPhase 1
  • Northwestern Medicine, Robert H. Lurie Comprehensive Cancer Center, Chicago
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT06925542

Platform Clinical Study for Conquering Scleroderma

Nagre-recruitPhase 2
  • The University of Chicago Medical Center (UCMC), Chicago
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 18, 2026 · NCT06195072

RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis

Nagre-recruitPhase 2/3
  • Northwestern Memorial Hospital, Chicago
  • The University of Chicago Medical Center, Chicago
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT06328777

A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)

Nagre-recruitPhase 1/2
  • Nkarta Investigational Site, Chicago
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Ago 7, 2026 · NCT06733935

Pag-aaral para sa Diffuse Scleroderma sa ibang lungsod

Iba pang pag-aaral sa Chicago

Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.